Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utilising triplet-triplet annihilation upconversion for overall photocatalytic water splitting.

Chemical communications (Cambridge, England)·2024
Same author

Confirming the Identity of Tuft Cells in Mouse Submandibular Glands.

Gastro hep advances·2023
Same author

An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.

BMC pulmonary medicine·2019
Same author

Association of metabolic syndrome with knee and hand osteoarthritis: A community-based study of women.

Seminars in arthritis and rheumatism·2018
Same author

A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk.

Respiratory medicine·2018
Same author

Negative magnetic resonance imaging in three cases of anterior tibial cortex stress fractures.

Skeletal radiology·2017
Same journal

Familial pulmonary fibrosis due to pathogenic TERT variant presenting with a UIP-PPFE phenotype.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Corkscrew Oesophagus Due to Distal Oesophageal Spasm.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Correction to: Integrated care management for patients following acute stroke: a systematic review.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Methodological concerns regarding blinding and long term efficacy of fire needle therapy for plaque psoriasis.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Media framing of GLP-1/GIP therapies in Japan: Lessons for aging universal health coverage systems.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Regional heterogeneity in psoriasis area and severity index response to fire needle therapy for plaque psoriasis.

QJM : monthly journal of the Association of Physicians·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

Fatigue in bronchiectasis.

K L M Hester1, J G Macfarlane, H Tedd

  • 1Freeman Hospital, Freeman Road, High Heaton, Newcastle upon Tyne, NE7 7DN, UK.

QJM : Monthly Journal of the Association of Physicians
|October 22, 2011
PubMed
Summary
This summary is machine-generated.

Fatigue in non-CF bronchiectasis correlates with breathlessness and lung function, but not Pseudomonas aeruginosa infection. Understanding these links is key for managing this disabling symptom.

Related Experiment Videos

Last Updated: May 28, 2026

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

Area of Science:

  • Pulmonology
  • Clinical Research
  • Respiratory Medicine

Background:

  • Fatigue is a significant and disabling symptom in non-CF bronchiectasis (nCF-Br).
  • The validated Fatigue Impact Scale (FIS) can measure fatigue.
  • The link between fatigue and disease severity markers like airflow obstruction, breathlessness, or Pseudomonas aeruginosa infection in nCF-Br is not well understood.

Purpose of the Study:

  • To quantify the association between FIS scores and indicators of disease severity in nCF-Br patients.
  • To explore correlations between fatigue and lung function, breathlessness, and P. aeruginosa status.

Main Methods:

  • A prospective cohort study design was employed.
  • 117 patients with nCF-Br were assessed for lung function (FEV(1)% predicted), Medical Research Council dyspnoea score (MRCD), and sputum culture for P. aeruginosa.
  • Patients were grouped based on P. aeruginosa presence: 'colonization', 'isolation', or neither.

Main Results:

  • Fatigue scores (FIS) showed significant correlations with MRCD scores (r=0.57, P<0.001) and FEV(1)% predicted (r=-0.30, P=0.001).
  • Patients with a history of P. aeruginosa isolation or colonization had lower FEV(1)% predicted (P≤0.001).
  • No significant association was found between P. aeruginosa status and fatigue levels (P=0.155 for colonization, P=0.31 for significant fatigue).

Conclusions:

  • FIS scores are significantly correlated with breathlessness (MRCD) and airflow obstruction (FEV(1)% predicted) in non-CF bronchiectasis.
  • While P. aeruginosa infection is linked to poorer lung function and increased breathlessness, it does not appear to significantly impact fatigue levels in this patient group.